Larvol Delta - Risk-of-Malignant-Melanoma-with-biologic-or-targeted-synthetic-diseasemodifying-therapies-in-patients-with-rheumatoid-arthritis-a-Swedish-Nationwide-Cohort-Study

Jyseleca (filgotinib) - Gilead

http://clinicaltrials.gov/ct2/show/NCT06222034

May 23, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next